Hematocure

From pandemic preparedness to precious frozen spit, NIH contract terminations cut deep DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35%

DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35%

www.statnews.com/2025/05/09/t...

Now online in Cancer Discovery: An Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer - by Wenyan Xie, Xin Yu, Qingxin Yang, Nengwen Ke, Ping Wang, Yun-Hua Liu, Bi-Sen Ding, Qiang Wei, Hong Jiang, and colleagues doi.org/10.1158/2159...

Federal Support for Cancer Research Takes the Stage at AACR Annual Meeting | Cancer Today Scientists and former administrators gather for session focused on advocating for cancer research in uncertain times.

#ICYMI: Scientists and former agency heads spoke about the crisis in public funding for cancer research at the AACR Annual Meeting 2025. Learn more in Cancer Today magazine: www.cancertodaymag.org/cancer-talk/... #AACR25

Myeloid neoplasms may arise after prior cytotoxic chemotherapy and/or large-field radiation therapy, commonly associated with TP53 mutations, and complex karyotype with frequent 5q/7q/17p loss. buff.ly/CnosfH9 #hemesky #bloodwork

FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline FDA announced an aggressive timeline to scale AI across all centers by June 30.

FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline

www.fda.gov/news-events/...

FDA misses another approval decision target date, this time for GSK's Nucala in COPD In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. | GSK had expected to secure an FDA no...

Delays at FDA continue as Agency misses approval decision target date for GSK's Nucala in COPD

www.fiercepharma.com/pharma/fda-m...

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies Glioblastoma is invariably lethal and responds poorly to immune checkpoint blockade. Here, we examined the impact of regulatory T (Treg) cell depletio…

Really happy to share this amazing story from my talented colleague Felipe Galvez-Cancino and many others. Really interesting work about the nature of anti-tumour immunity in the brain and how it can be modulated, in mice and humans!
www.sciencedirect.com/science/arti...

In a reversal, the Trump administration restores funding for women's health study The unexpected elimination of funding for the decades-long research project focused on women's health shocked scientists. They were heartened by the quick restoration of support.

The unexpected elimination of funding for the decades-long research project focused on women's health shocked scientists. They were heartened by the quick restoration of support.

Clonal Hematopoiesis as a Driver of Solid Tumors | NEJM Clonal hematopoiesis is the expansion of a genetically related population of hematopoietic stem and progenitor cells that disproportionately contribute to blood-cell production.1 Clonal hematopoies...

Clonal Hematopoiesis as a Driver of Solid Tumors

www.nejm.org/doi/full/10....

Cells are swapping their mitochondria. What does this mean for our health?

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat cancer and other diseases. 🧪🦠💊

www.nature.com/articles/d41...

Why an overreliance on AI-driven modeling could be bad for science

Editorial @jci-insight.bsky.social
Science: our past, our present, and always our future
insight.jci.org/articles/vie...

Perspective @jci-insight.bsky.social
Paving the physician-scientist career path: from grassroots gathering to national forum
insight.jci.org/articles/vie...

Research shows ferritin <30 µg/L indicates iron deficiency, but some labs still use a cutoff as low as 8 µg/L. This means thousands of people are told their iron levels are “normal” when they are deficient. Better screening is needed. Read the full article: https://bit.ly/4c901LU

🚨🎉🎊Congratulations to Blood Immunology & Cellular Therapy first published paper, Talquetamab in Heavily Pretreated Multiple Myeloma Patients, Including BCMA-Refractory. buff.ly/Y5Dh6hP

Texas judge strikes down FDA’s plan to regulate lab-developed tests The FDA has long believed it has the power to regulate lab-developed tests, but it only put out the rules under former President Biden.

Federal Court Vacates FDA Rule on Laboratory Developed Tests

www.statnews.com/2025/03/31/f...